News chronological

NPR (Michal Ruprecht) - The drug lenacapavir is a mighty weapon against HIV. Its rollout gets mixed reviews Thu Aug 13 11:18:53 2026

It's a twice-a-year injection that is remarkably effective in preventing an HIV infection. Distribution is starting. But questions are being raised about getting it to the areas that need it most.

AI:The distribution of lenacapavir, a highly effective twice-yearly injection designed to prevent HIV infection, has begun, though its rollout faces criticism regarding the logistics and equity of reaching high-need populations in regions like Uganda. This development follows a broader pattern of scrutiny surrounding pharmaceutical interventions and global health mandates, particularly as previous reports have highlighted concerns over vaccine safety, medical misinformation, and the influence of Big Pharma on clinical practices.Open

NPR (Kate Bartlett) - South Africa rolls out game-changing HIV shot amid funding shortfalls Fri Jun 5 14:53:26 2026

A new twice-yearly HIV prevention injection could transform South Africa's fight against the epidemic — but U.S. aid cuts and limited doses threaten to slow its impact.

NYTIMES (Stephanie Nolen and Arlette Bashizi) - A Powerful H.I.V. Drug Lands in Zambia. But Will It Reach Those Who Need It? Tue May 26 15:47:06 2026

Lenacapavir, which protects people from H.I.V. infection with twice-yearly shots, is arriving in a country where the health system has been hollowed out by American aid cuts.